2BB score and signals
SAB Biotherapeutics, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 20 | Low |
Company facts
| Headquarters | Miami Beach, Florida, United States |
| Founded | 2014 |
| Employees | 86 |
| 52-week range | $1.72 – $6.60 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.2921 | — | $0.00 |
| 2026-08-06 | — | -0.2952 | — | $0.00 |
| 2026-05-07 | — | -0.2171 | — | $0.00 |
| 2026-03-30 | — | -0.2027 | — | $0.00 |
2BBBullish & Bearish